Dongyuan Su
Key Laboratory Of Post Neuro Injury Neuro Repair And Regeneration In Central Nervous System
Tianjin, 300052, China
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis).
Journal: Neuro-oncology
Published: August 30, 2025
LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastoma.
Journal: Theranostics
Published: July 29, 2025
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization.
Journal: Neuro-oncology
Published: May 14, 2025
EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy.
Journal: Free radical biology & medicine
Published: January 09, 2025
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma.
Journal: Acta pharmaceutica Sinica. B
Published: June 26, 2024
CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Journal: Theranostics
Published: November 29, 2023
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
Journal: Cancer letters
Published: October 03, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
Journal: Neuro-oncology
Published: August 31, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026